RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $748,456 | -49.7% | 88,996 | -24.9% | 0.00% | 0.0% |
Q2 2023 | $1,489,227 | +11.0% | 118,569 | +45.6% | 0.00% | 0.0% |
Q1 2023 | $1,341,680 | +18.0% | 81,462 | +7.0% | 0.00% | 0.0% |
Q4 2022 | $1,137,173 | -21.2% | 76,116 | +18.0% | 0.00% | -50.0% |
Q3 2022 | $1,443,000 | +48.6% | 64,508 | +11.2% | 0.00% | +100.0% |
Q2 2022 | $971,000 | -1.6% | 58,011 | +75.9% | 0.00% | 0.0% |
Q1 2022 | $987,000 | +6.4% | 32,978 | +9.1% | 0.00% | – |
Q4 2021 | $928,000 | -10.4% | 30,218 | -8.0% | 0.00% | -100.0% |
Q3 2021 | $1,036,000 | -16.4% | 32,861 | -2.9% | 0.00% | 0.0% |
Q2 2021 | $1,239,000 | +22.3% | 33,835 | +15.4% | 0.00% | 0.0% |
Q1 2021 | $1,013,000 | -52.4% | 29,314 | -42.8% | 0.00% | 0.0% |
Q4 2020 | $2,128,000 | – | 51,223 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |